Drug Profile
NHP 07
Alternative Names: NHP-07Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator Predictive Therapeutics
- Class Antineoplastics; Cannabinoids; Hormonal contraceptives; Hormonal replacements; Hormones; Infertility therapies; Nonsteroidal anti-inflammatories; Pregnenediones; Progesterone congeners; Small molecules
- Mechanism of Action Glutamate antagonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Endometriosis
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for clinical-Phase-Unknown development in Endometriosis in USA
- 02 Jan 2018 Clinical research in Endometriosis in USA (unspecified route)